Pharmalot... Pharmalittle... Good Morning

Top of the morning to you. Gray skies may be hovering over the Pharmalot corporate campus today, but our spirits remain sunny as we recall a favorite expression from the indubitable Morning Mayor, who often opined that "every brand new day should be unwrapped like a precious gift." So while you tug on the proverbial ribbon, please join us for a cup of delicious stimulation - Pumpkin Spice is on the way - and take a look at some interesting items. Have a great day and drop us a line if you hear something juicy...

Bayer To Study Xarelto For Heart Attack Prevention (Reuters)

Mercks End Development Of Diabetes-Cholesterol Combo Pill (Dow Jones)

J&J Isn't Giving Up On Bapi Alzheimer Drug (Bloomberg News)

Least-Experienced Docs Are Highest Spenders: Study (Pharma Times)

A Merck Drug For Worms May Control Bed Bugs (Bloomberg News)

Nektar Stock Falls Over Risk Of Opioid Constipation Drug (MedCity News)

Croatia Arrests Pharma Execs And Docs On Bribery Charges (Associated Press)

Italy Arrests Several Cardiologists In Fraud Probe (CardioBrief)

Pakistan Ratifies Bill Creating Regulatory Authority (Express Tribune)

EDITOR'S NOTE: Please check thist post for updates

1 Comment

Nov 13, 2012 - 10:27am
Re the pharma times article, there is a truisim in clinical medicine which older doctors believe and younger doctors refuse to accept. That by taking a careful history and performing a thorough physical examination you can make a presumptive diagnosis 80% of the time before the first lab test is even ordered. In such cases the lab tests are or should be mostly confirmatory, with a minority being the costly workups.

Today's physicians, for example are more likely to whip somebody with stable angina into the cath lab than they are to take a careful history. Once in the cath lab the chances of stenting or angioplasty increase significantly, whereas most of these patients could be treated conservatively.